Dana Yarden

Dana Yarden has a diverse range of work experience in the medical and pharmaceutical industries. Dana started their career at BioLineRx, where they held multiple roles including Drug Development Manager, Medical Director, and Executive Director of Medical Affairs. Dana then worked at CollPlant as the Executive Director of Clinical & BD Affairs. Following this, they joined the MHA Program, where they served as a Manager, focusing on training healthcare managers.

In 2011, Dana became the CEO of Omer Therapeutics, a company specializing in preventive treatments for allergic disorders. Dana later became the CEO of SmartWave Medical, which developed an innovative treatment approach for atrial fibrillation.

Dana also co-founded BioBetter and GemmaCert, both of which focused on innovation in the medical and pharmaceutical industries. Currently, they serve as the Executive Director at WuXi AppTec, leading their representative office in Israel and providing outsourcing solutions to the life sciences industry.

Dana Yarden holds a Bachelor of Medicine (MD) degree from Tel Aviv University, which was acquired between 1997 and 2005. Dana further pursued their education and obtained a Master of Health Administration (MHA) degree from the same institution, completing the program from 2004 to 2006. Dana later pursued higher education and completed a Master of Business Administration (MBA) degree at Tel Aviv University from 2006 to 2008.